(Q38041587)

27 August 2017

title

Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application (English)

1 reference

27 August 2017

2

Olufunmilayo I Olopade

1 reference

27 August 2017

Uchenna O Njiaju

1

1 reference

27 August 2017

publication date

1 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

18

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

436-442

1 reference

Linkage of early-onset familial breast cancer to chromosome 17q21

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Inherited breast and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Inherited susceptibility to common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Hereditary breast cancer: from bench to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

How many more breast cancer predisposition genes are there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

The genetic epidemiology of breast cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Genetic susceptibility loci for breast cancer by estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Finishing the euchromatic sequence of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Familial risk of cancer and knowledge and use of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Cancer genetic risk assessment and referral patterns in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Very high risk of cancer in familial Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Clinical implications of low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

A common coding variant in CASP8 is associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2012.01274.X

10.1111/J.1524-4741.2012.01274.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference